Co-Diagnostics, Inc. CODX
$1.14
$0.032.70%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 1.96% | 190.26% | -60.08% | -29.72% | 1.12% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 1.96% | 190.26% | 76.76% | -77.32% | -93.87% |
| Cost of Revenue | 41.12% | 797.22% | -44.18% | -91.16% | -84.87% |
| Gross Profit | -7.65% | -266.55% | 214.95% | -65.35% | -94.65% |
| SG&A Expenses | -38.70% | -13.38% | -63.62% | -55.40% | -23.10% |
| Depreciation & Amortization | -30.75% | -8.92% | -25.06% | -23.86% | -13.86% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -22.55% | 8.74% | -34.28% | -34.17% | -20.47% |
| Operating Income | 23.05% | -7.68% | 35.67% | 31.47% | -4.92% |
| Income Before Tax | 18.83% | -21.51% | -137.51% | 27.09% | -1.84% |
| Income Tax Expenses | 56.10% | -95.83% | -5,676.83% | -5,354.95% | -40.29% |
| Earnings from Continuing Operations | 18.71% | -21.33% | -133.39% | 39.29% | -1.72% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 18.71% | -21.33% | -133.39% | 39.29% | -1.72% |
| EBIT | 23.05% | -7.68% | 35.67% | 31.47% | -4.92% |
| EBITDA | 22.76% | -8.24% | 36.00% | 31.74% | -5.79% |
| EPS Basic | 79.18% | 42.48% | -27.52% | 51.14% | 7.45% |
| Normalized Basic EPS | 80.19% | 48.85% | 65.93% | 42.98% | 1.07% |
| EPS Diluted | 79.16% | 42.43% | -26.73% | 50.00% | 7.45% |
| Normalized Diluted EPS | 80.19% | 48.85% | 65.93% | 42.98% | 1.07% |
| Average Basic Shares Outstanding | 290.54% | 110.94% | 83.03% | 24.25% | 9.90% |
| Average Diluted Shares Outstanding | 290.54% | 110.94% | 83.03% | 24.25% | 9.90% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |